Clinical trials: Adverse Effects in the Therapeutic Use of Plasma Substitutes
Adverse Effects in the Therapeutic Use of Plasma Substitutes
A Prospective Non-interventional Study to Evaluate the Safety of Methylene Blue Plasma
The objective of this non-interventional study is to gather data on adverse reactions occurring with Methylene Blue plasma administered in a routine clinical practice environment; to know more about their characteristics and…
- Trial name
- NCT02007473
- Where
- 4 sites in Belgium, Greece and 2 more
- Volunteers
- 8 people
- Sponsor
- Maco Productions S.A.S.
Adverse Effects in the Therapeutic Use of Plasma Substitutes
Octaplas Pediatric Plasma Exchange Trial
To assess the safety and tolerability of octaplas™ in the pediatric population by monitoring serious adverse drug reactions, adverse drug reactions (ADRs), thrombotic events (TEs), thromboembolic events (TEEs) and by measuring…
- Trial name
- Octaplas (NCT01938378)
- Testing
- Octaplas™
- Where
- 8 sites in United States
- Volunteers
- 41 people
- Sponsor
- Octapharma